Andreas M. Brosig

ORCID: 0000-0003-3533-4695
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pancreatitis Pathology and Treatment
  • Psychedelics and Drug Studies
  • Liver Disease Diagnosis and Treatment
  • Complementary and Alternative Medicine Studies
  • Pancreatic and Hepatic Oncology Research
  • Renal Transplantation Outcomes and Treatments
  • Vaccine Coverage and Hesitancy
  • SARS-CoV-2 and COVID-19 Research
  • Adenosine and Purinergic Signaling
  • Silymarin and Mushroom Poisoning
  • COVID-19 Clinical Research Studies

University Hospital Regensburg
2022-2025

Background: Acute severe pancreatitis is associated with high morbidity and mortality. Hypertriglyceridemia the third most common cause of acute higher triglyceride levels increase risk for pancreatitis. Plasma exchange an effective treatment method to lower triglycerides. Our study aimed investigate efficiency plasma as a option hypertriglyceridemia-induced (HTGP), impact on mortality assessed by SOFA, SAPS II, BISAP Score, Ranson’s, Glasgow-Imrie Criteria, well overall length stay in...

10.1159/000529975 article EN cc-by Digestive Diseases 2023-01-01

Abstract Background Mushrooms, an integral component of human diets, range from esteemed delicacies to potentially lethal toxins. The risk severe poisoning misidentified species, poses a significant challenge. For clinicians, recognizing mushroom amidst nonspecific symptoms and determining the specific ingested are critical yet complex tasks. Additionally, climate change affects distribution proliferation heightening exposure toxic varieties. identification intoxication is for appropriate...

10.1186/s12876-024-03550-y article EN cc-by BMC Gastroenterology 2024-12-17

The COVID-19 pandemic reached Bavaria in February 2020. Almost simultaneously, Chinese physicians published reports on the first successful treatments with plasma from convalescent donors. With these silver linings horizon, we decided to establish manufacturing of anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody-containing donors at our site. Here describe donor selection process, built ground up, which enabled us cope immense resonance after social media call for...

10.1002/hsr2.815 article EN cc-by-nc-nd Health Science Reports 2022-09-01
Coming Soon ...